{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:02:33Z","timestamp":1794445353182,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"40","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2024,9,27]]},"DOI":"10.1038\/s41388-024-03139-5","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T06:02:57Z","timestamp":1724824977000},"page":"2971-2985","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["m6A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis"],"prefix":"10.1038","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2541-2683","authenticated-orcid":false,"given":"Kaixuan","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5627-9650","authenticated-orcid":false,"given":"Yongbo","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0527-945X","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2902-6533","authenticated-orcid":false,"given":"Youmiao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengda","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4413-776X","authenticated-orcid":false,"given":"Wenbang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9689-8622","authenticated-orcid":false,"given":"Yuanhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7360-1582","authenticated-orcid":false,"given":"Fengyan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2425-6946","authenticated-orcid":false,"given":"Lijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1552-948X","authenticated-orcid":false,"given":"Chaohui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"3139_CR1","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney L. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38:1895\u2013904. https:\/\/doi.org\/10.1007\/s00345-019-02984-4.","journal-title":"World J Urol"},{"key":"3139_CR2","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/s0140-6736(22)01188-6","volume":"400","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, et al. Current best practice for bladder cancer: a narrative review of diagnostics and treatments. Lancet (Lond, Engl). 2022;400:1712\u201321. https:\/\/doi.org\/10.1016\/s0140-6736(22)01188-6.","journal-title":"Lancet (Lond, Engl)"},{"key":"3139_CR3","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/551S33a","volume":"551","author":"M Grayson","year":"2017","unstructured":"Grayson M. Bladder cancer. Nature. 2017;551:S33. https:\/\/doi.org\/10.1038\/551S33a.","journal-title":"Nature"},{"key":"3139_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7:378. https:\/\/doi.org\/10.1038\/s41392-022-01229-y.","journal-title":"Signal Transduct Target Ther"},{"key":"3139_CR5","doi-asserted-by":"publisher","first-page":"C186","DOI":"10.1152\/ajpcell.00132.2018","volume":"315","author":"T Fukai","year":"2018","unstructured":"Fukai T, Ushio-Fukai M, Kaplan JH. Copper transporters and copper chaperones: roles in cardiovascular physiology and disease. Am J Physiol Cell Physiol. 2018;315:C186\u2013c201. https:\/\/doi.org\/10.1152\/ajpcell.00132.2018.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3139_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14:6523. https:\/\/doi.org\/10.1038\/s41467-023-42025-8.","journal-title":"Nat Commun"},{"key":"3139_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12964-018-0277-3","volume":"16","author":"J Kardos","year":"2018","unstructured":"Kardos J, H\u00e9ja L, Simon \u00c1, Jablonkai I, Kov\u00e1cs R, Jemnitz K. Copper signalling: causes and consequences. Cell Commun Signal: CCS. 2018;16:71. https:\/\/doi.org\/10.1186\/s12964-018-0277-3.","journal-title":"Cell Commun Signal: CCS"},{"key":"3139_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/1535370220911604","volume":"245","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Wang T, Song X, Yang D, Chu Q, Kang YJ. Copper promotion of myocardial regeneration. Exp Biol Med (Maywood, NJ). 2020;245:911\u201321. https:\/\/doi.org\/10.1177\/1535370220911604.","journal-title":"Exp Biol Med (Maywood, NJ)"},{"key":"3139_CR9","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.tips.2018.10.001","volume":"39","author":"SL Sensi","year":"2018","unstructured":"Sensi SL, Granzotto A, Siotto M, Squitti R. Copper and Zinc Dysregulation in Alzheimer\u2019s Disease. Trends Pharmacol Sci. 2018;39:1049\u201363. https:\/\/doi.org\/10.1016\/j.tips.2018.10.001.","journal-title":"Trends Pharmacol Sci"},{"key":"3139_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41589-018-0089-1","volume":"14","author":"J Rihel","year":"2018","unstructured":"Rihel J. Copper on the brain. Nat Chem Biol. 2018;14:638\u20139. https:\/\/doi.org\/10.1038\/s41589-018-0089-1.","journal-title":"Nat Chem Biol"},{"key":"3139_CR11","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1039\/c9mt00148d","volume":"11","author":"H Yang","year":"2019","unstructured":"Yang H, Liu CN, Wolf RM, Ralle M, Dev S, Pierson H, et al. Obesity is associated with copper elevation in serum and tissues. Metallomics: Integr Biometal Sci. 2019;11:1363\u201371. https:\/\/doi.org\/10.1039\/c9mt00148d.","journal-title":"Metallomics: Integr Biometal Sci"},{"key":"3139_CR12","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.biochi.2009.05.011","volume":"91","author":"LB M\u00f8ller","year":"2009","unstructured":"M\u00f8ller LB, Mogensen M, Horn N. Molecular diagnosis of Menkes disease: genotype-phenotype correlation. Biochimie. 2009;91:1273\u20137. https:\/\/doi.org\/10.1016\/j.biochi.2009.05.011.","journal-title":"Biochimie"},{"key":"3139_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","volume":"4","author":"A Cz\u0142onkowska","year":"2018","unstructured":"Cz\u0142onkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease. Nat Rev Dis Prim. 2018;4:21. https:\/\/doi.org\/10.1038\/s41572-018-0018-3.","journal-title":"Nat Rev Dis Prim"},{"key":"3139_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neulet.2013.04.057","volume":"547","author":"Y Noda","year":"2013","unstructured":"Noda Y, Asada M, Kubota M, Maesako M, Watanabe K, Uemura M, et al. Copper enhances APP dimerization and promotes A\u03b2 production. Neurosci Lett. 2013;547:10\u20135. https:\/\/doi.org\/10.1016\/j.neulet.2013.04.057.","journal-title":"Neurosci Lett"},{"key":"3139_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15:174. https:\/\/doi.org\/10.1186\/s13045-022-01392-3.","journal-title":"J Hematol Oncol"},{"key":"3139_CR16","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1039\/c5mt00149h","volume":"7","author":"D Denoyer","year":"2015","unstructured":"Denoyer D, Masaldan S, La Fontaine S, Cater MA. Targeting copper in cancer therapy: \u2018Copper That Cancer. Metallomics: Integr Biometal Sci. 2015;7:1459\u201376. https:\/\/doi.org\/10.1039\/c5mt00149h.","journal-title":"Metallomics: Integr Biometal Sci"},{"key":"3139_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science (N.Y., NY). 2022;375:1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529.","journal-title":"Science (N.Y., NY)"},{"key":"3139_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol cancer. 2023;22:46. https:\/\/doi.org\/10.1186\/s12943-023-01732-y.","journal-title":"Mol cancer"},{"key":"3139_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.981764","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu J, Hu Z, Cao H, Zhang H, Luo P, Zhang J, et al. Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma. Front Immunol. 2022;13:981764. https:\/\/doi.org\/10.3389\/fimmu.2022.981764.","journal-title":"Front Immunol"},{"key":"3139_CR20","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300980R","volume":"37","author":"H Wen","year":"2023","unstructured":"Wen H, Qu C, Wang Z, Gao H, Liu W, Wang H, et al. Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT\/mTOR pathway in prostate cancer. FASEB J: Off Publ Federation Am Societies Exp Biol. 2023;37:e23145. https:\/\/doi.org\/10.1096\/fj.202300980R.","journal-title":"FASEB J: Off Publ Federation Am Societies Exp Biol"},{"key":"3139_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114301","volume":"159","author":"W Yang","year":"2023","unstructured":"Yang W, Wang Y, Huang Y, Yu J, Wang T, Li C, et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed Pharmacother = Biomedecine pharmacotherapie. 2023;159:114301. https:\/\/doi.org\/10.1016\/j.biopha.2023.114301.","journal-title":"Biomed Pharmacother = Biomedecine pharmacotherapie"},{"key":"3139_CR22","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.18632\/aging.202359","volume":"13","author":"W Song","year":"2021","unstructured":"Song W, Yang K, Luo J, Gao Z, Gao Y. Dysregulation of USP18\/FTO\/PYCR1 signaling network promotes bladder cancer development and progression. Aging. 2021;13:3909\u201325. https:\/\/doi.org\/10.18632\/aging.202359.","journal-title":"Aging"},{"key":"3139_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01267-6","volume":"19","author":"J Li","year":"2020","unstructured":"Li J, Xie H, Ying Y, Chen H, Yan H, He L, et al. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Mol cancer. 2020;19:152. https:\/\/doi.org\/10.1186\/s12943-020-01267-6.","journal-title":"Mol cancer"},{"key":"3139_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8849218","volume":"2020","author":"Q Gao","year":"2020","unstructured":"Gao Q, Zheng J, Ni Z, Sun P, Yang C, Cheng M, et al. The m(6)A Methylation-Regulated AFF4 Promotes Self-Renewal of Bladder Cancer Stem Cells. Stem cells Int. 2020;2020:8849218. https:\/\/doi.org\/10.1155\/2020\/8849218.","journal-title":"Stem cells Int"},{"key":"3139_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol cancer. 2022;21:14. https:\/\/doi.org\/10.1186\/s12943-022-01500-4.","journal-title":"Mol cancer"},{"key":"3139_CR26","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1016\/j.bbamcr.2013.06.028","volume":"1833","author":"R Sano","year":"2013","unstructured":"Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochimica et biophysica acta. 2013;1833:3460\u201370. https:\/\/doi.org\/10.1016\/j.bbamcr.2013.06.028.","journal-title":"Biochimica et biophysica acta"},{"key":"3139_CR27","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1158\/2159-8290.Cd-14-1507","volume":"5","author":"B Qiu","year":"2015","unstructured":"Qiu B, Ackerman D, Sanchez DJ, Li B, Ochocki JD, Grazioli A, et al. HIF2\u03b1-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. Cancer Discov. 2015;5:652\u201367. https:\/\/doi.org\/10.1158\/2159-8290.Cd-14-1507.","journal-title":"Cancer Discov"},{"key":"3139_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.molcel.2007.12.023","volume":"29","author":"U Ozcan","year":"2008","unstructured":"Ozcan U, Ozcan L, Yilmaz E, D\u00fcvel K, Sahin M, Manning BD, et al. Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol cell. 2008;29:541\u201351. https:\/\/doi.org\/10.1016\/j.molcel.2007.12.023.","journal-title":"Mol cell"},{"key":"3139_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/imr.13276","volume":"321","author":"WQ Liu","year":"2024","unstructured":"Liu WQ, Lin WR, Yan L, Xu WH, Yang J. Copper homeostasis and cuproptosis in cancer immunity and therapy. Immunol Rev. 2024;321:211\u201327. https:\/\/doi.org\/10.1111\/imr.13276.","journal-title":"Immunol Rev"},{"key":"3139_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol. 2022;12:952290. https:\/\/doi.org\/10.3389\/fonc.2022.952290.","journal-title":"Front Oncol"},{"key":"3139_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958368","volume":"13","author":"Q Song","year":"2022","unstructured":"Song Q, Zhou R, Shu F, Fu W. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer. Front Immunol. 2022;13:958368. https:\/\/doi.org\/10.3389\/fimmu.2022.958368.","journal-title":"Front Immunol"},{"key":"3139_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20:303\u201322. https:\/\/doi.org\/10.1038\/s41568-020-0253-2.","journal-title":"Nat Rev Cancer"},{"key":"3139_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","volume":"28","author":"X Deng","year":"2018","unstructured":"Deng X, Su R, Weng H, Huang H, Li Z, Chen J. RNA N(6)-methyladenosine modification in cancers: current status and perspectives. Cell Res. 2018;28:507\u201317. https:\/\/doi.org\/10.1038\/s41422-018-0034-6.","journal-title":"Cell Res"},{"key":"3139_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020;19:88. https:\/\/doi.org\/10.1186\/s12943-020-01204-7.","journal-title":"Mol Cancer"},{"key":"3139_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.825109","volume":"12","author":"Q Liu","year":"2021","unstructured":"Liu Q. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer. Front Genet. 2021;12:825109. https:\/\/doi.org\/10.3389\/fgene.2021.825109.","journal-title":"Front Genet"},{"key":"3139_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01508-w","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, Li H, Hu D, Wang Y, Shao W, Zhong J, et al. Insights into N6-methyladenosine and programmed cell death in cancer. Mol cancer. 2022;21:32. https:\/\/doi.org\/10.1186\/s12943-022-01508-w.","journal-title":"Mol cancer"},{"key":"3139_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-022-00269-y","volume":"11","author":"X Chen","year":"2022","unstructured":"Chen X, Zhou X, Wang X. m(6)A binding protein YTHDF2 in cancer. Exp Hematol Oncol. 2022;11:21. https:\/\/doi.org\/10.1186\/s40164-022-00269-y.","journal-title":"Exp Hematol Oncol"},{"key":"3139_CR38","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1158\/0008-5472.Can-22-2485","volume":"83","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li Y, Zhou L, Zhou H, Ye L, Ou T, et al. The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response. Cancer Res. 2023;83:1834\u201350. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2485.","journal-title":"Cancer Res"},{"key":"3139_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116247","volume":"172","author":"Y Zhong","year":"2024","unstructured":"Zhong Y, Zeng W, Chen Y, Zhu X. The effect of lipid metabolism on cuproptosis-inducing cancer therapy. Biomed Pharmacother = Biomedecine pharmacotherapie. 2024;172:116247. https:\/\/doi.org\/10.1016\/j.biopha.2024.116247.","journal-title":"Biomed Pharmacother = Biomedecine pharmacotherapie"},{"key":"3139_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10495-023-01928-z","volume":"29","author":"T Chen","year":"2024","unstructured":"Chen T, Liang L, Wang Y, Li X, Yang C. Ferroptosis and cuproptposis in kidney Diseases: dysfunction of cell metabolism. Apoptosis: Int J Program cell death. 2024;29:289\u2013302. https:\/\/doi.org\/10.1007\/s10495-023-01928-z.","journal-title":"Apoptosis: Int J Program cell death"},{"key":"3139_CR41","doi-asserted-by":"publisher","unstructured":"Zhang W, Wang M, Liu B, Chen H, Tan J, Meng Q, et al. Glutathione Induced In situ Synthesis of Cu Single-Atom Nanozymes with Anaerobic Glycolysis Metabolism Interference for Boosting Cuproptosis. Angewandte Chemie (International ed in English) 2024:e202402397. https:\/\/doi.org\/10.1002\/anie.202402397.","DOI":"10.1002\/anie.202402397"},{"key":"3139_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059.","journal-title":"Cancer Discov"},{"key":"3139_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04867-8","volume":"22","author":"L Zhou","year":"2024","unstructured":"Zhou L, Du K, Dai Y, Zeng Y, Luo Y, Ren M, et al. Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer. J Transl Med. 2024;22:55. https:\/\/doi.org\/10.1186\/s12967-024-04867-8.","journal-title":"J Transl Med"},{"key":"3139_CR44","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.celrep.2019.04.005","volume":"27","author":"M Ni","year":"2019","unstructured":"Ni M, Solmonson A, Pan C, Yang C, Li D, Notzon A, et al. Functional Assessment of Lipoyltransferase-1 Deficiency in Cells, Mice, and Humans. Cell Rep. 2019;27:1376\u201386.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.04.005.","journal-title":"Cell Rep"},{"key":"3139_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbalip.2016.08.011","volume":"1862","author":"AJ Kastaniotis","year":"2017","unstructured":"Kastaniotis AJ, Autio KJ, Ker\u00e4t\u00e4r JM, Monteuuis G, M\u00e4kel\u00e4 AM, Nair RR, et al. Mitochondrial fatty acid synthesis, fatty acids and mitochondrial physiology. Biochimica et biophysica acta Mol cell Biol lipids. 2017;1862:39\u201348. https:\/\/doi.org\/10.1016\/j.bbalip.2016.08.011.","journal-title":"Biochimica et biophysica acta Mol cell Biol lipids"},{"key":"3139_CR46","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1158\/0008-5472.Can-23-0969","volume":"83","author":"L Zhou","year":"2023","unstructured":"Zhou L, Luo Y, Liu Y, Zeng Y, Tong J, Li M, et al. Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression. Cancer Res. 2023;83:3920\u201339. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0969.","journal-title":"Cancer Res"},{"key":"3139_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","volume":"42","author":"W Wang","year":"2023","unstructured":"Wang W, Lu K, Jiang X, Wei Q, Zhu L, Wang X, et al. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer. J Exp Clin Cancer Res: CR. 2023;42:142. https:\/\/doi.org\/10.1186\/s13046-023-02720-2.","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"3139_CR48","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7150\/thno.49384","volume":"11","author":"L Zhou","year":"2021","unstructured":"Zhou L, Song Z, Hu J, Liu L, Hou Y, Zhang X, et al. ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3. Theranostics. 2021;11:841\u201360. https:\/\/doi.org\/10.7150\/thno.49384.","journal-title":"Theranostics"},{"key":"3139_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bcp.2018.02.019","volume":"151","author":"HJ Park","year":"2018","unstructured":"Park HJ, Son HJ, Sul OJ, Suh JH, Choi HS. 4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts. Biochem Pharmacol. 2018;151:9\u201317. https:\/\/doi.org\/10.1016\/j.bcp.2018.02.019.","journal-title":"Biochem Pharmacol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03139-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T09:03:21Z","timestamp":1727427801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-024-03139-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":49,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2024,9,27]]}},"alternative-id":["3139"],"URL":"https:\/\/doi.org\/10.1038\/s41388-024-03139-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}